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The  immune  response  of inbred  strains  of mice  to  the  random  terpolymer 
L-glutamic  acid6°-L-alanine~°-L-tyrosine  1°  (GAT) 1 is  controlled  by  a  specific 
immune  response  (Ir)  gene  which maps  in  the  I  region  of  the  H-2  complex 
between  the K  and S  regions  (1,  2).  In preceding papers,  a  technique was de- 
scribed  for  the  detection  of  primary  GAT-specific  IgG  plaque-forming  cell 
(PFC)  responses in mouse spleen  cell cultures.  PFC  responses to soluble  GAT 
were  obtained  with  spleen  cells  from  the  responder  strains,  C57BL/6  (H-2  b) 
and A/J (H-2a),  but not from the nonresponder strains,  SJL, and the congenic 
resistant  strains  B10.S  and  A.SW,  all  of  which  are  H-2".  Spleen  cells  from 
(C57BL/6  X  SJL)F1  (H-2bl 0  mice  responded  to  GAT as well  as  spleen  cells 
from the responder parental  strain  (3,  4).  In spite of their inability  to respond 
to GAT, H-2 ~ spleen  cells,  like H-2  b spleen  cells,  developed  GAT-specific IgG 
PFC  responses  to  GAT  complexed  to  an  immunogenic  carrier,  methylated 
bovine serum albumin  (GAT-MBSA),  demonstrating  that  nonresponder H-2" 
B  cells are capable of producing antibody specific for GAT if appropriate helper 
T  cells  are  activated  (3). 
In further  studies,  the  cellular  requirements  for the  development  of GAT- 
specific PFC responses to GAT and GAT-MBSA by spleen cells from responder 
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and  nonresponder mice were  investigated  (4).  Macrophages  are  required  to 
support  the viability of lymphoid cells in  culture  and  to present  antigen to 
immunocompetent cells (5). Nanogram amounts of GAT bound to nonresponder 
H-28  macrophages were able to elicit anti-GAT PFC  responses by responder 
splenic 1)~mphoid cells equally as well as GAT bound to responder macrophages, 
indicating that the failure of H-28  spleen cells to respond to GAT is not the 
result of a defect in macrophage function. In contrast, GAT bound to responder 
macrophages  could  not  elicit  responses  in  cultures  of  nonresponder  splenic 
lymphoid cells,  showing that the genotype of the macrophage does not deter- 
mine responder-nonresponder status  in mice (4). We have also demonstrated 
that anti-GAT responses, both to GAT and to GAT-MBSA, are abolished by 
treatment of spleen cells with anti-theta  (0)  serum and  complement (C)  be- 
fore culture initiation and are, therefore, thymus dependent (4). Collectively, 
these data  strongly suggested that the defect in genetic nonresponder spleen 
cells is the failure of their T cells, after interaction with soluble GAT, to provide 
appropriate helper function for initiation of the B-cell response. 
In  the  recent studies by Kindred and  Shreffler (6)  and by our laboratory 
(7, 8), carrier specific T  cells were shown to be unable to provide helper func- 
tion for histoincompatible B  cells.  However, sharing of a single H-2 haplotype 
was  nevertheless  sufficient  for  successful  T-  and  B-cell  cooperation  in  the 
response to conventional antigens  such  as keyhole limpet hemocyanin. Thus, 
for these antigens, F1 T  cells were able to provide efficient helper function for B 
cells from both parental strains. In contrast, if the response to the carrier moiety 
of the antigen is under Ir gene control, carrier-primed T  cells from an F1 hybrid 
of responder and nonresponder strains, could provide effective helper function 
only for responder,  but  not  for  nonresponder,  parental  B  cells in  a  double 
adoptive transfer system in vivo (9). This finding raised intriguing questions 
concerning a possible role of Ir genes in B cells. 
In  the present study, the analysis of the  cellular requirements for the de- 
velopment of GAT-specific PFC responses was pursued to investigate further: 
(a)  the  conditions for successful T- and  B-cell interaction in  vitro;  and  (b) 
whether  functional  differences between  responder  and  nonresponder  B  cells 
could be detected. More specifically, a study was made of the requirements for 
in vitro cooperative interactions between nonresponder B 10.S B cells and spleen 
cells from primed irradiated responder (C57BL/6 X  SJL)F1 mice, as a source 
of T cells, in cultures to which soluble GAT, GAT-MBSA, or GAT bound to F1 
macrophages was added. 
Materials and Methods 
Mice.--C57BL/6J  (H-gb), SJL/J  (H-2'), and DBA/1  (H-2q)  mice were purchased from 
Jackson Laboratories, Bar Harbor, Maine. B10.S mice, a congenic-resistant strain of mice of 
the H-2' haplotype on a  C57BL/10 background were a gift from D. Shreftter,  University of 
Michigan, Ann Arbor, Mich., and were bred in our animal facilities. F1 hybrid mice (H-2 b/') 
from C57BL/6  X  SJL/J matings were produced in our animal facilities and have the same B.  BENACERRAF,  J.  A.  KAPP,  C.  W.  PIERCE,  D.  H.  KATZ  187 
H-2 haplotype as F1 mice from a  C57BL/6  X  B10.S  (H-2b/O mating. Mice used in these 
experiments were  2-  to  8-mo  old  and  were  maintained  on  laboratory chow  and  acidified 
chlorinated water ad libitum. 
Antigens.--The  synthetic linear random terpolymer  GAT,  mol wt 32,000,  used in these 
studies  was  synthesized  by  Miles Laboratories,  Inc.  Miles  Research  Div.,  Kankakee,  IlL 
Preparation  of  GAT,  GAT-MBSA,  and  GAT bound  to  (C57BL/6  X  SJL)F1  peritoneal 
macrophages  (GAT-Mq~)  for addition to culture was previously described  in detail  (4,  5). 
Various amounts of soluble GAT, GAT-MBSA containing 5 #g GAT, or 7 X  104 macrophages 
bearing 1-2 ng of GAT were added to cultures according to the experimental protocol. 
Spleen Cell Cultures and PFC Assay.--Techniques  of spleen cell culture and the hemolytic 
plaque assay using GAT-SRBC as indicator cells have been described previously (3, 4). 
Immunization of Mice.--(C57BL/6 )< SJL)F1 mice were injected intraperitoneally with 10 
#g GAT, or 10/zg GAT as GAT-MBSA, or 50/zg MBSA in a mixture of magnesium-aluminum 
hydroxide gel  (Maalox,  Wm.  H.  Rorer, Inc., Fort  Washington, Pa.)  and pertussis vaccine 
(Eli Lilly & Co., Indianapolis, Ind.) as previously described (1, 2). 
Preparation of B Cells.--O-bearing T  cells were eliminated from normal spleen cell suspen- 
sions by treatment with AKR anti-0 C3H  serum and  C  before culture initiation (4). As a 
control, a  portion of the spleen cell suspensions were treated with C alone. After treatment, 
10 X  106 cells in MEM were added to cultures with or without additional cells and with GAT, 
GAT-MBSA, or GAT-M$ according to the experimental protocol. 
Source of T  Cells.--The  helper cell function of antigen-primed T  cells has been demon- 
strated to be radioresistant, whereas B  cells and normal unprimed T  cells are radiosensitive 
(10). Previous studies from our laboratories have established the conditions for using irradiated 
carrier-primed spleen cells as a source of helper T  cells for cooperative antibody responses to 
soluble antigens in vitro  (11).  Therefore,  F1 mice primed  !-4 mo earlier with GAT,  GAT- 
MBSA, or MBSA were X irradiated with 700-800 R delivered by a General Electric Maximar 
250 Type III X-ray therapy unit (250 Kvp, 15 mA) at 36 R/min through 0.5 mm Cu, 1.0 mm 
Al filters (General Electric Co., Chemical  & Medical Div. Schenectady, N.  Y.).  Within 3 h 
after X  irradiation, the mice were sacrificed and single cell suspensions prepared from their 
spleens. 10 X  106 cells in MEM were added to cultures with or without additional cells and 
with GAT, GAT. MBSA, or GAT-M~b according to the experimental protocol. 
RESULTS 
Failure of Nonresponder (H-20  B  Cells to Devdop PFC Respanses to Soluble 
GA T In Vitro in the Presence of GA T-Primed  (H-2bI*)F1 T Cells.--In an initial 
series of experiments, we compared the ability of GAT-MBSA-primed irradi- 
ated (C57BL/6 X  SJL)F1 spleen cells, as a source of specific T  cells,  to provide 
helper function for responder C57BL/6 or nonresponder B10.S B  cells in  re- 
sponses to soluble GAT or GAT-MBSA. To this end, 10 X  106 normal C5?BL/6 
or  B10.S  B  cells were mixed  with  an  equal  number of  GAT-MBSA-primed 
irradiated (C57BL/6)<  SJL)F1 spleen cells and incubated with  10 #g soluble 
GAT or 5/zg GAT as GAT-MBSA. The results of this experiment are shown 
in Fig.  1.  C57BL/6 spleen cells developed GAT-specific IgG PFC responses 
to both soluble GAT and GAT-MBSA, whereas B10.S spleen cells developed 
GAT  responses  only  to  GAT-MBSA,  not  to  GAT.  Treatment  with  anti-6 
serum and  C  abolished these responses by spleen cells from both B10.S  and 
C57BL/6 mice. Antigen-primed irradiated T  cells cultured alone did not re- 
spond  to  GAT.  If,  however, B10.S  or  C57BL/6 B  cells were  cultured  with 188  GENETIC  CONTROL  OF  IMMUNE  RESPONSES  IN  VITRO 
FlO. 1.  Soluble GAT (10 #g) or GAT-MBSA  containing 5 #g GAT was added to cultures 
of 10 X  106 C-treated spleen cells from normal C57BL/6 or B10.S mice and to cultures con- 
taining either (a)  10  X  106 anti-0 plus C-treated spleen cells plus 10 X  106 GAT-MBSA- 
primed irradiated  (C57BL/6 X  SJL)Ft spleen cells or (b) cultures containing 7 X  106 anti-0 
plus C-treated spleen cells  plus 7 X 106 F1 T cells. 
irradiated GAT-MBSA-primed (C57BL/6 X  SJL)F1 spleen cells, the responses 
are  restored;  C57BL/6  B  cells  developed  GAT responses  to  both  GAT  and 
GAT-MBSA, whereas BI0.S B  cells developed GAT-specific responses only to 
GAT-MBSA, not to soluble GAT. 
This experiment demonstrates that B  cells from nonresponder B10.S  (H-2*) 
animals, in contrast to responder C57BL/6 (H-2  b) B cells, cannot be stimulated 
by soluble GAT in spite of the presence of functional GAT-primed F1  (H-2  bt') 
T  cells bearing the H-2* haplotype of the B  cell.  The inability of B10.S B  cells 
to  respond  to  soluble  GAT in  this  system cannot be ascribed  to  nonspecific 
suppressor activity generated in these cultures,  because, as shown by the last 
two groups in Fig.  1, the addition of B10.S  B  cells to cultures of C57BL/6 B 
cells and the same primed F1 T  cells did not diminish the response to GAT. 
Role of Macrophage  Presentation  of GA T  in the Development  of In Vitro PFC 
Responses  by Nonresponder  H-2* B  Cells in the Presence of GA T-Primed 1I-2  bl* 
F~  T  cells.--Comparative  studies  of the  susceptibility of responder  C57BL/6 
and  nonresponder H-2 ~ and H-D spleen cells to tolerance induction  by  GAT 
reported in the companion paper (12)  have shown that nonresponder cells ex- 
posed to GAT in vivo or in vitro are rapidly rendered unresponsive to stimula- 
tion  with  GAT-MBSA,  under  conditions  where  spleen  cells  from  responder 
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be considered, therefore, that the failure of soluble GAT to elicit responses by 
B10.S  B  cells in the presence of functional  GAT-primed responder F1 T  cells 
may reflect a  greater susceptibility to tolerance induction  of nonresponder B 
cells in the presence of what is less than optimal T-cell helper function for these 
B cells. This interpretation is also supported by findings that GAT presented on 
macrophages in very small amounts (1-2 rig)  is strongly immunogenic for re- 
sponder spleen cells (4) but not for nonresponder spleen cells (Table I). Further- 
more, 1-2 ng of GAT in soluble form (12) or bound to macrophages, are unable 
to tolerize nonresponder spleen cells (Table I). As shown, the development of an 
immune response to GAT-MBSA by nonresponder,  but not responder spleen 
cells was inhibited by 5 #g soluble GAT. 7 X  104 normal syngeneic macrophages 
TABLE I 
Effect of Macrophage-Bound GA T  on the Immune  Response to GAT-MBSA  in  Vitro 
ANTIGEN 
IgG GAT-specific PFC/culture 
C57BI,/6  DBA/1 
5 #g GAT  415  <10 
GAT-MBSA  175  420 
GAT-MBSA +  5 #g GAT  290  15 
GAT-MBSA +  NM~*  260  295 
GAT-M~b*  410  < 10 
GAT-MBSA +  GAT-M~*  250  325 
GAT-M~b*  335 
* Syngeneic M~b added to spleen cell cultures. 
J; DBA/1 GAT-Mq~  added to C57BL/6 spleen cell cultures. 
were added to one set of cultures stimulated with GAT-MBSA for comparison 
with cultures receiving 7  X  104 GAT-Mq~  and cultures receiving GAT-MBSA 
plus  7  X  104  GAT-M$.  GAT bound  to macrophages did  not inhibit  the re- 
sponse to GAT-MBSA by either responder or nonresponder spleen cells.  As a 
control for the effectiveness of GAT bound to DBA/1 macrophages, it can be 
seen that these cells were able to elicit a GAT-specific PFC response in cultures 
of C57BL/6 spleen cells but not in cultures of DBA/1 spleen cells. 
Since GAT bound to macrophages was nontolerogenic for nonresponder spleen 
cells,  experiments were carried out to ascertain whether GAT bound to macro- 
phages  from  (C57BL/6  X  SJL)F1  animals  could  stimulate  GAT-specific re- 
sponses in  cultures  of B10.S  B  cells and  GAT-MBSA or  GAT-primed FIT 
cells.  The results of these experiments are presented in Figs. 2 and 3.  In these 
and all remaining experiments to be described,  the same protocol used in the 
studies presented  in  Fig.  1 was employed. B-cell populations from responder 
C57BL/6 and nonresponder B10.S spleens were cultured with irradiated spleen 
cells from F1 mice primed to GAT, GAT-MBSA, or MBSA as a source of helper 
T  cells.  To these cell mixtures, antigen either in soluble form, or aggregated as 
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FIG. 2.  Soluble  GAT (10 #g) or GAT-MBSA  containing  5 #g GAT or 7 X 104 (C57BL/6 X 
SJL)F1 macrophages  plus 10/zg soluble GAT or 7 X 104 (C57BL/6 X SJL)F1 macrophages 
bearing 1-2 ng of GAT were added to cultures. 10 X l0  s C-treated, anti-0 plus C-treated and 
X-irradiated GAT-MBSA-primed (C57BL/6 X SJL)F1 spleen cell suspensions were added to 
cultures as designated. 
The data presented in  Figs.  2 and 3 demonstrate that nonresponder B10.S 
B cells  can be induced to develop anti-GAT PFC responses in the presence of 
GAT-specific F1 T cells, if GAT in nanogram amounts is presented on (C57BL/6 
X  SJL)F1 macrophages. Similar results were obtained whether the (C57BL/6 X 
SJL)F1 T  cells  were primed  to GAT-MBSA (Fig.  2)  or to GAT (Fig.  3)  and 
whether  GAT  was  presented  on  (C57BL/6  X  SJL)F1,  C57BL/6,  or  SJL 
macrophages (not shown). As a further comparison of the ability of B10.S and 
C57BL/6 B  cells  to develop GAT-specific PFC responses when cultured with 
macrophage bound GAT, these cells were incubated, in the presence of GAT- 
primed Fa T  cells, with various numbers, 3.5  X  103 X-7104, of F1 macrophages 
bearing  GAT.  Both  responder  and  nonresponder  B  cells  developed  GAT- 
specific  PFC  responses when incubated with  as few  as 7  X  103 GAT-bearing 
macrophages, whereas neither responder nor  nonresponder  B  cells  developed 
responses when cultured with 3.5  X  10  ~ macrophages bearing GAT. Thus, no 
difference between  responder  and  nonresponder B  cells  in  their  ability  to be 
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FIo. 3.  The same general protocol as that in Figs. 1 and 2 was used. The source of T cells 
was from irradiated (C57BL/6 X SJL)F1 mice primed with GAT in Maalox-pertussis. 
It is important  to note  that  the  response of B10.S  B  cells to macrophage- 
bound GAT required that responder (C57BL/6  X  SJL)F1 T  cells were primed 
to GAT. GAT-specific PFC  responses could not be elicited by GAT bound to 
macrophages in  the  absence  of  GAT-primed  responder  F,  T  cells.  Thus,  as 
shown in Fig. 4, when F1 T  cells primed only to MBSA were used, GAT bound 
to macrophages did not stimulate anti-GAT PFC responses in cultures of either 
C57BL/6 or B10.S B  cells.  These cell populations responded adequately, how- 
ever, to GAT-MBSA. 
The  addition  of  F1  macrophages  and  GAT  separately  to  the  cultures,  as 
illustrated in Fig. 2, did not stimulate development of anti-GAT P FC responses 
in cultures of B10.S B  cells and GAT-MBSA-primed F, cells.  Thus, F1 macro- 
phages not bearing  GAT when added  to culture cannot stimulate a  response, 
presumably because the  soluble  GAT tolerizes B10.S  B  cells before they  are 
able to respond to any GAT which becomes bound to macrophages in culture 
(as will be shown in  Fig.  5).  In contrast,  if GAT is added  to the  cultures  as 
insoluble GAT-MBSA, B10.S B cells are able to cooperate effectively with GAT- 
primed F1 T  cells and are able to develop GAT-specific PFC responses (Fig. 3) 
in  the  absence of MBSA-primed T  cells.  It is well established  that  insoluble 192  GENETIC  CONTROL OF  IMMUNE RESPONSES  IN  VITRO 
FIG. 4.  See legend for Fig.  2 for protocol. In  this experiment antigen-primed irradiated 
spleen cells were prepared from  (C57BL/6  X  S.[L)F1 mice immunized with GAT-MBSA or 
MBSA in  Maalox-pertussis. These cells  cultured  alone did not respond to  GAT  or  GAT- 
MBSA. In this experiment 5/zg soluble GAT were added to designated cultures. 
aggregates,  in  contrast  to  soluble  antigens,  are very effectively taken  up by 
macrophages  (13).  It is,  therefore, very probable that  the response of B10.S 
B  cells observed in this experiment is explained by the presentation of GAT- 
MBSA  on  macrophages  and  the  absence  of  free  soluble  GAT  in  sufficient 
amounts to tolerize the highly susceptible B10.S B cells. 
Inhibition  of the  Responses  of BIO.S B  Cells  and GAT-Prirned H-2  bl~ F1  T 
Cells to Macrophage-Bound GA T  by Soluble GA T.--In the experiments that we 
have just described, nonresponder B10.S B cells were found to respond, in the 
presence of GAT-primed responder F1 T  cells,  only when GAT was bound to 
macrophages and  not  to  concentrations of soluble  GAT which  stimulate  re- 
sponses by responder C57BL/6 B cells. It is relevant, therefore, to inquire what 
effect soluble GAT, added at the initiation of culture, had on the PFC responses 
stimulated by macrophage-bound GAT. The data presented in Fig. 5 demon- 
strate  that  soluble  GAT  almost  completely inhibits  the  GAT-specific PFC B.  BENACERRAF,  J.  A.  KAPP,  C.  W.  PIERCE,  D.  H.  KATZ  193 
FIG. 5.  See legend  for Fig. 2. 
responses elicited by macrophage-bound GAT in cultures of B10.S B cells and 
GAT-MBSA-primed F1 T  cells. In this experiment, the response of C57BL/6 B 
cells and the primed F1 T  cells to macrophage-bound GAT was also inhibited 
somewhat  by  soluble  GAT;  the  response  approximated  that  stimulated  by 
soluble GAT alone. However, the degree of inhibition of the anti-GAT response 
in cultures of C57BL/6 B cells was much smaller than that observed in cultures 
of B10.S B cells and was not observed in every experiment, whereas the nearly 
complete inhibition of anti-GAT responses by B10.S B  cells by soluble GAT 
could always be demonstrated. 
DISCUSSION 
In previous reports from this laboratory, some of the genetic requirements 
for cooperative interactions among T  and  B  cells in  the mouse were defined 
(7-9). Helper T  cells and B  cells must share one H-2 haplotype for successful 
interactions to occur in the response to conventional thymus-dependent antigens 
and their hapten conjugates. However, when the response to the carrier moiety 
of the antigen is under control of a  specific Ir gene, as is the response to the 
random  terpolymer  of  L-glutamic  acid 5~,  L-lysine  88,  and  L-tyrosine  5 (GLT), 194  GENETIC  CONTROL  OF  IMMUNE  RESPONSES  IN  VITRO 
GLT-specific (responder X  nonresponder)F1 T  cells could provide helper func- 
tion only for B  cells of the responder parent bearing the relevant Ir  gene for 
GLT in the development of a response to DNP-GLT and not for B cells of the 
nonresponder parent lacking the Ir gene for GLT. These experiments could be 
interpreted to indicate that the specific Ir genes are necessarily expressed in B 
cells as well as in T  cells where Ir gene function has been conclusively demon- 
strated (14). Alternatively, the conclusion could be reached that a close spatial 
relationship exists between the products of the genes in the H-2 complex con- 
trolling T- and B-cell cooperation and the products of the Ir genes and, there- 
fore, that those products of that H-2 haplotype, where the relevant Ir gene is 
located, are  activated in T  cells for optimal cooperative interaction with  the 
corresponding products on the B cell coded for by the same haplotype (9). 
The present investigations of the cellular requirements for the response to 
GAT in vitro have permitted an analysis of these possibilities and present an 
explanation  for  the  absence  of  cooperative interaction  between  primed  (re- 
sponder  X  nonresponder)F1 T  cells and nonresponder B  cells in this system. 
The same restrictions observed in the DNP-GLT system in vivo were indeed 
observed with  the GAT system in vitro. Nonresponder B10.S B  cells did not 
develop  GAT-specific PFC  responses  when  exposed  to  soluble  GAT  in  the 
presence of GAT-primed responder (C57BL/6  X  SJL)F1 T  cells, whereas re- 
sponder C57BL/6 B cells developed excellent responses under these conditions. 
The failure of the B10.S B cells to respond in this system was clearly shown not 
to be attributable to the generation of nonspecific suppressor substances in the 
cultures since B10.S B cells added to the mixtures of C57BL/6 B cells and GAT- 
primed (C57BL/6 X  SJL)Fi spleen cells did not diminish the response to GAT 
in these cultures. 
However, B10.S  B  cells were shown  to  cooperate with  GAT-primed F~ T 
cells and to develop a  response to GAT when the polymer was presented on 
macrophages.  This mode of presentation of antigen is  required to  avoid the 
greater tolerogenic property of soluble  GAT for nonresponder (H-20  B  cells 
than for responder (H-2  b) B cells in the presence of GAT-primed H-2  bl~ T  cells. 
Macrophage-bound  GAT,  although  added  to  spleen  cultures  in  nanogram 
amounts,  was  shown  to be  both  strongly immunogenic for responder spleen 
cells and not capable of inducing B-cell tolerance in nonresponder cells.  It is 
not inconsistent,  therefore, that anti-GAT responses developed in cultures of 
nonresponder B 10.S B cells and irradiated GAT-primed responder (C57BL/6 X 
SJL)F1 spleen cells to which GAT bound to macrophages was added, irrespec- 
tive of the  source of the macrophages used,  responder, nonresponder, or F~. 
This response could be clearly inhibited if 10/~g of soluble GAT were added to 
the culture. 
Several important issues are raised by these findings: (a) Are the results ob- 
tained in vitro with the  GAT system applicable to the GLT system in vivo? 
Or  can successful cooperation be observed in vivo between GLT-primed (re- B.  BENACERRAF,  J.  A.  KAPP~ C.  W.  PIERCE,  D.  H.  KATZ  195 
sponder X  nonresponder)F1 T  cells and nonresponder hapten-specific B cells if 
the hapten conjugate of GLT is administered Oil macrophages? This question 
has been asked in  a  double adoptive transfer experiment using irradiated F1 
recipients reported elsewhere (15). Macrophages which bound DNP-GLT failed 
to  stimulate  DNP-specific nonresponder parental  B  cells in  the  presence of 
irradiated GLT-primed F1 T  cells,  although they were able to stimulate anti- 
DNP responses from DNP-primed parental responder B cells. Thus, confirma- 
tion of the results whereby macrophage-bound GAT could induce a response by 
B10.S B cells in vitro with the help of responder F1 T  cells could not be dupli- 
cated in the GLT system in vivo. 
(b)  Why  then,  do  (responder  X  nonresponder)F1  T  cells  provide  what 
appears to be inadequate helper function for parental nonresponder B cells and 
excellent helper function for parental responder B  cells when stimulated with 
soluble GAT compared to the adequate helper cell function for both responder 
and  nonresponder B  cells when  the  antigen  was  administered  in  very small 
amounts on macrophages or in  insoluble form as  GAT-MBSA that  is  easily 
bound to macrophages? Or to put it in other terms, why are nonresponder B cells 
rendered tolerant so much more readily than responder B cells by soluble GAT 
in culture or in vivo (12)? At this time, it cannot be ruled out that this differ- 
ence between responder and nonresponder B cells reflects the expression of the 
Ir gene product in responder B cells in the same way as it was demonstrated in 
responder T  cells (14). However, if this is the case, specific Ir genes would not 
be clonally expressed in B  cells and,  therefore, could not reasonably be con- 
cerned with specificity since all Ir genes would be expressed in each B cell. This 
conclusion is not consistent with  the remarkable specificity exhibited by the 
recognition which different specific Ir genes control (14). Another hypothesis 
may also account for the available data. Results from several laboratories indi- 
cate that B cells are very easily rendered tolerant by multivalent antigens in the 
absence of activated functional helper T  cells (16). Thus, hapten conjugates of 
heterologous carriers render hapten-specific B cells unresponsive to subsequent 
challenge with the conjugate used for primary immunization because of what 
would  appear  to  be an  insufficient number of helper T  cells specific for the 
second carrier for the number of primed B cells when this hapten-carrier conju- 
gate is administered (17). The data presented in the companion paper where 
tolerance is readily induced in nonresponder B  cells in  the presence of what 
appears to be less than adequate helper function for nonresponder B cells may 
be another  example  of the  crucial  role played by the  signal  contributed by 
activated T cells in preventing the induction of B-cell tolerance. 
(c)  If indeed this interpretation is correct, the issue to be considered, then, is 
why are  (responder X  nonresponder)Fx T  cells very ineffective in providing 
helper function for nonresponder B cells but quite effective in providing helper 
function for responder B  cells for antigens under Ir gene control when antigen 
is soluble? This state of affairs may be related to the possibility, hypothesized 196  GENETIC  CONTROL  OF  IMMUNE  RESPONSES  IN  VITRO 
previously  (9), that  the  gene product(s)  concerned  with  T-B-cell interaction 
which might be activated by these antigens in responder F1 T  cells is that of the 
responder allele, whereas effective stimulation of the nonresponder B cell might 
require the activation of the allelic gene product coded for in the nonresponder 
H-2 haplotype common to the nonresponder B cell. The fact that macrophage- 
bound antigen  is able to remedy this apparent restriction is very informative 
and shows that the T-cell signal which is unable to stimulate nonresponder B 
cells incubated  with  soluble  GAT is received by these  B  cells if the  GAT is 
presented in a nontolerogenic form on the surface o~ macrophages. 
A  fundamental difference exists, therefore, between the ability of responder 
and nonresponder B cells to cooperate with F1 T  cells in the presence of soluble 
GAT. In the presence of F1 T  cells, responder B ceils can be stimulated by solu- 
ble GAT or GAT bound to macrophages, whereas nonresponder B  cells can be 
stimulated only if GAT is bound to macrophages. 
This raises the issue of whether  antigen  bound  to macrophages is particu- 
larly efficient in  stimulating B  cells as well as T  cells as compared with  free 
soluble antigen  which is much more tolerogenic. In our experiments, however, 
such interactions between antigen bound  to macrophages and B  cells did not 
obviate the necessity for the essential contribution of GAT-primed T  cells for 
the development of anti-GAT responses by B10.S B cells. 
Lastly, the experiments reported herein demonstrate that genetic disparity 
at Ir loci is not an absolute barrier to T-B-cell cooperative interactions in the 
response  to  antigens  under  Ir  gene  control  which  may  indeed  explain  the 
observations of Bechtol et al. (18), that allophenic mice derived from responder 
and  nonresponder  strains  may produce  antibodies  of  nonresponder  allotype 
under  conditions of hyperimmunization. 
SUMMARY 
The  conditions  for  cooperative  interactions  between  nonresponder  B10.S 
B cells and GAT-primed irradiated (C57BL/6 X  SJL)F1 T  cells in the response 
by cultures of mouse spleen cells to CAT were investigated. GAT-specific anti- 
body responses could be elicited by soluble GAT in cultures of GAT-primed ir- 
radiated  (C57BL/6  X  SJL)FI  T  cells  with  C57BL/6  B  cells  but  not  with 
B10.S B cells. 
In contrast, when GAT was presented to the cultures on F1 macrophages or 
as aggregates of GAT with MBSA, GAT-specific PFC responses were observed 
with  both  B10.S  or  C57BL/6  B  cells.  Irradiated  GAT-primed T  cells  were 
nevertheless  essential  for  the  development  of  these  responses.  The  GAT- 
specific response of B10.S B cells in these cultures was inhibited by the addition 
of soluble  GAT at  culture  initiation.  These results indicate  that  genetic  dis- 
parity at Ir loci is not an absolute barrier to T-B-cell cooperative interactions 
in the response to antigens under Ir gene control. The significance of these data 
for the function of Ir gene products in immunocompetent cells is discussed. 
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